Dr. Jesse Sengillo, MD

Dr. Sengillo practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Sengillo's NPI, 1053803957, was assigned on June 6, 2018. Dr. Sengillo holds Florida license ME155650.

Dr. Sengillo's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Sengillo's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Sengillo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sengillo practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sengillo's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sengillo is licensed in Florida.

CMS data shows 119 Medicare services from Dr. Sengillo across 5 procedure codes in 2024, for 118 Medicare patients. Medicare paid $6,100 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Dr. Sengillo in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sengillo's median patient age at 75, with 59% women.

In 2024, Dr. Sengillo wrote 1,667 Medicare Part D claims for 387 patients. 73% of them were for generic drugs. CMS names the drug for 1,571 of them, across 21 drugs with 11 or more claims each, at $57,139 in total drug cost. In 2023, CMS named 1,022 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sengillo for performance year 2024, reported as part of a group. Dr. Sengillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Sengillo, published from 2023 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Tomography, Optical Coherence, Fluorescein Angiography and Fundus Oculi. Dr. Sengillo has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Sengillo's most frequent co-authors are Landon James Rohowetz, MD, Marissa Katherine Shoji and Jayanth Srinivasan-Kasi Sridhar, MD.

CMS Open Payments shows 35 general payments to Dr. Sengillo from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 83% of the total. Alcon Laboratories Inc paid the most, $2,283.